Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-08-004017
Filing Date
2008-06-06
Accepted
2008-06-06 10:59:25
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 4277
  Complete submission text file 0001005477-08-004017.txt   6146
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PINE STREET PHILADELPHIA PA 19106
Business Address
UPRICHARD DAVID C (Reporting) CIK: 0001239916 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 08884654